Corient Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.16M | Sell |
56,590
-63,754
| -53% | -$8.07M | 0.01% | 658 |
|
2025
Q1 | $15.4M | Buy |
120,344
+45,010
| +60% | +$5.76M | 0.03% | 430 |
|
2024
Q4 | $9.72M | Sell |
75,334
-9,680
| -11% | -$1.25M | 0.02% | 521 |
|
2024
Q3 | $12.4M | Sell |
85,014
-4,003
| -4% | -$583K | 0.02% | 498 |
|
2024
Q2 | $12.2M | Sell |
89,017
-554
| -0.6% | -$76K | 0.02% | 482 |
|
2024
Q1 | $12.3M | Buy |
89,571
+2,871
| +3% | +$394K | 0.02% | 479 |
|
2023
Q4 | $11.8M | Buy |
86,700
+841
| +1% | +$114K | 0.02% | 482 |
|
2023
Q3 | $10.5M | Sell |
85,859
-4,277
| -5% | -$523K | 0.02% | 466 |
|
2023
Q2 | $11.4M | Sell |
90,136
-6,447
| -7% | -$819K | 0.03% | 453 |
|
2023
Q1 | $12.5M | Buy |
96,583
+35,405
| +58% | +$4.57M | 0.03% | 401 |
|
2022
Q4 | $8.03M | Buy |
+61,178
| New | +$8.03M | 0.03% | 407 |
|